Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.
2.
3.

Membrane transport and antitumor activity of pirarubicin, and comparison with those of doxorubicin.

Sugiyama T, Sadzuka Y, Nagasawa K, Ohnishi N, Yokoyama T, Sonobe T.

Jpn J Cancer Res. 1999 Jul;90(7):775-80.

PMID:
10470291
4.

Theanine and glutamate transporter inhibitors enhance the antitumor efficacy of chemotherapeutic agents.

Sugiyama T, Sadzuka Y.

Biochim Biophys Acta. 2003 Dec 5;1653(2):47-59. Review.

PMID:
14643924
5.

Enhancement of the activity of doxorubicin by inhibition of glutamate transporter.

Sadzuka Y, Sugiyama T, Suzuki T, Sonobe T.

Toxicol Lett. 2001 Sep 15;123(2-3):159-67.

PMID:
11641044
6.

Inhibition of glutamate transporter by theanine enhances the therapeutic efficacy of doxorubicin.

Sugiyama T, Sadzuka Y, Tanaka K, Sonobe T.

Toxicol Lett. 2001 Apr 30;121(2):89-96.

PMID:
11325559
7.

Modulation of cancer chemotherapy by green tea.

Sadzuka Y, Sugiyama T, Hirota S.

Clin Cancer Res. 1998 Jan;4(1):153-6.

8.

In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.

Quintieri L, Rosato A, Napoli E, Sola F, Geroni C, Floreani M, Zanovello P.

Cancer Res. 2000 Jun 15;60(12):3232-8.

9.

Improved in vivo antitumor efficacy and reduced systemic toxicity of carboxymethylpullulan-peptide-doxorubicin conjugates.

Nogusa H, Hamana H, Uchida N, Maekawa R, Yoshioka T.

Jpn J Cancer Res. 2000 Dec;91(12):1333-8.

PMID:
11123434
10.

Efficacies of tea components on doxorubicin induced antitumor activity and reversal of multidrug resistance.

Sadzuka Y, Sugiyama T, Sonobe T.

Toxicol Lett. 2000 Apr 3;114(1-3):155-62.

PMID:
10713480
12.

Antimetastatic effect by anti-adhesion therapy with cell-adhesive peptide of fibronectin in combination with anticancer drugs.

Saiki I, Yoneda J, Kobayashi H, Igarashi Y, Komazawa H, Ishizaki Y, Kato I, Azuma I.

Jpn J Cancer Res. 1993 Mar;84(3):326-35.

PMID:
8486531
13.

[Glutamate transporter mediated increase of antitumor activity by theanine, an amino acid in green tea].

Sadzuka Y, Yamashita Y, Kishimoto S, Fukushima S, Takeuchi Y, Sonobe T.

Yakugaku Zasshi. 2002 Nov;122(11):995-9. Japanese.

14.

Enhancement of doxorubicin concentration in the M5076 ovarian sarcoma cells by cucurbitacin E co-treatment.

Sadzuka Y, Hatakeyama H, Sonobe T.

Int J Pharm. 2010 Jan 4;383(1-2):186-91. doi: 10.1016/j.ijpharm.2009.08.040. Epub 2009 Sep 2.

PMID:
19732815
15.

Effect of verapamil on doxorubicin activity and pharmacokinetics in mice bearing resistant and sensitive solid tumors.

Formelli F, Cleris L, Carsana R.

Cancer Chemother Pharmacol. 1988;21(4):329-36.

PMID:
3370742
16.

Improvement of idarubicin induced antitumor activity and bone marrow suppression by theanine, a component of tea.

Sadzuka Y, Sugiyama T, Sonobe T.

Cancer Lett. 2000 Oct 1;158(2):119-24.

PMID:
10960760
17.

Efficacy of theanine is connected with theanine metabolism by any enzyme, not only drug metabolizing enzymes.

Sadzuka Y, Sugiyama T, Nagamine M, Umegaki K, Sonobe T.

Food Chem Toxicol. 2006 Feb;44(2):286-92. Epub 2005 Sep 6.

PMID:
16140449
18.

Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model.

Saucier JM, Yu J, Gaikwad A, Coleman RL, Wolf JK, Smith JA.

J Oncol Pharm Pract. 2007 Mar;13(1):39-45.

PMID:
17621566
19.

The effects of theanine, as a novel biochemical modulator, on the antitumor activity of adriamycin.

Sadzuka Y, Sugiyama T, Miyagishima A, Nozawa Y, Hirota S.

Cancer Lett. 1996 Aug 2;105(2):203-9.

PMID:
8697445
20.

The effect of taurine, a novel biochemical modulator, on the antitumor activity of doxorubicin.

Sadzuka Y, Matsuura M, Sonobe T.

Biol Pharm Bull. 2009 Sep;32(9):1584-7.

Supplemental Content

Support Center